ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+22.28%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$507M
AUM Growth
+$507M
(+6.2%)
Cap. Flow
-$5.68M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
74.82%
Holding
77
New
18
Increased
7
Reduced
8
Closed
10
Top Buys
| 1 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$12.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$9.73M |
| 3 |
Sarepta Therapeutics
SRPT
|
$7.93M |
| 4 |
Viking Therapeutics
VKTX
|
$7.12M |
| 5 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$6.42M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$26M |
| 2 |
Ascendis Pharma
ASND
|
$15.5M |
| 3 |
Arrowhead Research
ARWR
|
$9.95M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$7.42M |
| 5 |
Tandem Diabetes Care
TNDM
|
$6.68M |
Sector Composition
| 1 | Healthcare | 75.18% |
| 2 | Communication Services | 0% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Rocket Pharmaceuticals
RCKT
$354M
| – | – | -350,000 | Closed | -$6.56M |
|